Generation and Evaluation of a Newcastle Disease Virus–Based H9 Avian Influenza Live Vaccine
Authors:
- Guobin TianGTGuobin Tian
- Xianying ZengXZXianying Zeng
- Yongping JiangYJYongping Jiang
- Hualan ChenHCHualan Chen
- Zhigao BuZBZhigao Bu
- 1 March 2010
- journal article
- research article
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 54 (s1) , 294-296
Abstract
Infection with H9 avian influenza virus (AIV) and Newcastle disease virus (NDV) are two important causes of egg drop in layer and breeder poultry, leading to severe economic loss in the industry. Currently in China, inactivated H9 AIV vaccine and live attenuated NDV vaccine have to be repeatedly administered to prevent egg drop in layer animals. Using reverse genetics, we constructed a recombinant NDV expressing an H9 AIV hemagglutinin (HA) from an H9N2 field isolate, A/Chicken/Shandong/2/2007. The HA gene was inserted into the intergenic region between the phosphoprotein (P) and matrix (M) genes of the LaSota NDV vaccine strain. The recombinant virus stably expressing the HA gene, rL-H9, was found to be innocuous after intracerebral inoculation of 1-day-old chickens. A single dose of 106 50% egg infectious dose of the recombinant virus intranasally inoculated into chickens induced high levels of NDV- and AIV H9-specific hemagglutination-inhibition antibody. Complete protection from clinical dise... RESUMEN. Nota de Investigación—Generación y evaluación de una vacuna viva recombinante para el virus de la influenza aviar H9 utilizando como vector al virus de la enfermedad de Newcastle. Las infecciones con los virus de la influenza aviar H9 y con el virus de la enfermedad de Newcastle son dos causas importantes de baja en la producción de huevo en aves ponedoras de huevo comercial y en reproductoras, lo que ocasiona pérdidas económicas severas a la industria. Actualmente en China, se deben administrar de manera repetida una vacuna inactivada para la influenza aviar H9 y una vacuna viva atenuada para la enfermedad de Newcastle, con el fin de prevenir bajas en la producción en aves de postura. Mediante reversión genética, se construyó un virus de Newcastle recombinante que expresa a la hemaglutinina H9 de un aislamiento de campo del virus de la influenza aviar denominado A/pollo/Shandong/2/2007 subtipo H9N2. El gene de la hemaglutinina fue insertado en la región intergénica entre los genes de la fosfopro...Keywords
This publication has 12 references indexed in Scilit:
- Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza VirusesJournal of Virology, 2007
- Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle diseaseProceedings of the National Academy of Sciences, 2006
- Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenzaProceedings of the National Academy of Sciences, 2006
- Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickensProceedings of the National Academy of Sciences, 2005
- Evolution of H9N2 influenza viruses from domestic poultry in Mainland ChinaVirology, 2005
- Isolation and identification of swine influenza recombinant A/Swine/Shandong/1/2003(H9N2) virusMicrobes and Infection, 2004
- Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle DiseaseAvian Diseases, 2003
- A decade after the generation of a negative-sense RNA virus from cloned cDNA – what have we learned?Journal of General Virology, 2002
- Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of IranAvian Pathology, 2002
- Recombinant Newcastle Disease Virus as a Vaccine VectorJournal of Virology, 2001